US 11814440
Glypican 2 as a cancer marker and therapeutic target
granted A61KA61K2039/572A61K2300/00
Quick answer
US patent 11814440 (Glypican 2 as a cancer marker and therapeutic target) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/572, A61K2300/00, A61K35/17, A61K39/39558